Peak6 Investments LLC Alnylam Pharmaceuticals, Inc. Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

A detailed history of Peak6 Investments LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Peak6 Investments LLC holds 29,700 shares of ALNY stock, worth $7.29 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

29,700

Previous 8,400 253.57%

Holding current value

$7.29 Million

Previous $2.04 Million 300.24%

% of portfolio

0.02%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$233.81 - $287.01 $487,961 - $598,989	-2,087 Reduced 77.93%	591 $162,000
Q2 2024 Aug 13, 2024	SELL	$143.31 - $247.0 $790,927 - $1.36 Million	-5,519 Reduced 67.33%	2,678 $650,000
Q1 2024 May 14, 2024	BUY	$146.51 - $198.2 $489,050 - $661,591	3,338 Added 68.7%	8,197 $1.23 Million
Q4 2023 Feb 13, 2024	SELL	$151.41 - $196.57 $1.25 Million - $1.62 Million	-8,253 Reduced 62.94%	4,859 $930,000
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $809,962 - $1 Million	4,743 Added 56.67%	13,112 $2.32 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $294,350 - $337,371	1,591 Added 23.47%	8,369 $1.59 Million
Q1 2023 May 12, 2023	BUY	$182.66 - $235.53 $632,916 - $816,111	3,465 Added 104.59%	6,778 $1.36 Million
Q4 2022 Feb 10, 2023	SELL	$185.53 - $241.31 $451,023 - $586,624	-2,431 Reduced 42.32%	3,313 $788,000
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $795,773 - $1.33 Million	5,744 New	5,744 $1.15 Million
Q4 2021 Feb 11, 2022	BUY	$159.56 - $209.29 $750,570 - $984,500	4,704 New	4,704 $798,000
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $2.52 Million - $3.08 Million	-14,820 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $1.9 Million - $2.61 Million	-14,751 Reduced 49.88%	14,820 $2.51 Million
Q4 2020 Feb 12, 2021	BUY	$122.97 - $147.0 $2.14 Million - $2.56 Million	17,438 Added 143.72%	29,571 $3.84 Million
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $2.47 Million - $3.38 Million	-20,396 Reduced 62.7%	12,133 $1.77 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $539,912 - $810,515	-5,181 Reduced 13.74%	32,529 $4.82 Million
Q1 2020 May 14, 2020	BUY	$93.12 - $133.99 $3.36 Million - $4.83 Million	36,056 Added 2179.93%	37,710 $4.11 Million
Q4 2019 Feb 13, 2020	SELL	$74.51 - $124.23 $1.83 Million - $3.05 Million	-24,577 Reduced 93.69%	1,654 $190,000
Q3 2019 Nov 08, 2019	BUY	$70.9 - $87.82 $1.48 Million - $1.83 Million	20,861 Added 388.47%	26,231 $2.11 Million
Q2 2019 Aug 14, 2019	BUY	$65.86 - $92.79 $353,668 - $498,282	5,370 New	5,370 $390,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account

Peak6 Investments LLC Alnylam Pharmaceuticals, Inc. Transaction History